Fractyl Health, Inc. (GUTS) Price & Analysis

Compare

222 Followers

GUTS Stock Chart & Stats

Day’s Range― - ―

52-Week Range$0.83 - $3.48

Previous Close$1.96

Volume269.01K

Average Volume (3M)5.06M

Market Cap

$177.14M

Enterprise Value$118.88M

Total Cash (Recent Filing)$22.29M

Total Debt (Recent Filing)$61.72M

Price to Earnings (P/E)―

Beta1.35

Next Earnings

Nov 18, 2025

EPS Estimate

-0.32

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.56

Shares Outstanding132,193,770

10 Day Avg. Volume6,008,176

30 Day Avg. Volume5,056,754

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.67

Enterprise Value/Revenue6.99K

Enterprise Value/Gross Profit-216.14

Enterprise Value/Ebitda-1.18

Forecast

1Y Price Target

$6.52

Price Target Upside382.96% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering6

Bulls Say, Bears Say

Bulls Say

Analyst ActionFollowing Fractyl’s positive pivotal midpoint analysis for Revita as weight maintenance post-GLP1 discontinuation, the analyst raises the price objective to $5 per share.

Clinical Trial ResultsFractyl announced positive midpoint randomized cohort results from the ongoing pivotal REMAIN-1 clinical trial evaluating Revita DMR procedure for weight loss/maintenance after GLP-1 RA discontinuation.

Safety ProfileNo adverse events were reported in Rejuva-treated animals, indicating a favorable safety profile.

Bears Say

Clinical Trial TimelineThe pivotal trial is fully enrolled, and GUTS projects randomization to complete in early 2026.

Fractyl Health, Inc. News

Fractyl Health announces preclinical results from RJVA-002

Fractyl Health (GUTS) announced new preclinical data from RJVA-002, the second candidate from the Company’s Rejuva Smart GLP-1...

8d ago

GUTS

Biotech Alert: Searches spiking for these stocks today

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by...

16d ago

GUTS

Fractyl Health price target raised to $5 from $4 at BofA

BofA analyst Jason Gerberry raised the firm’s price target on Fractyl Health (GUTS) to $5 from $4 and...

16d ago

GUTS

Fractyl Health price target lowered to $8 from $9 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Fractyl Health (GUTS) to $8 from $9 and keeps a...

19d ago

GUTS

Fractyl Health prices 60M shares at $1.00 in underwritten offering

Fractyl Health (GUTS) announced the pricing of an underwritten offering of 60 million shares of its common stock...

19d ago

GUTS

Fractyl Health announces REMAIN-1 study met 3-month efficacy endpoint

Fractyl Health (GUTS) announced results from the REMAIN-1 Midpoint Cohort, supporting the potential for Revita to be the...

19d ago

GUTS

Fractyl Health initiated with a Buy at H.C. Wainwright

H.C. Wainwright initiated coverage of Fractyl Health (GUTS) with a Buy rating and $9 price target Fractyl is...

30d ago

GUTS

Promising Potential of Fractyl Health’s Innovative Gene Therapy for Obesity Earns Buy Rating

H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Fractyl Health, Inc. today and set a price...

8d ago

GUTS

Fractyl Health Approves Share Issuance in Special Meeting

The latest announcement is out from Fractyl Health, Inc. ( ($GUTS) ). On October 3, 2025, Fractyl Health,...

11d ago

GUTS

Positive Outlook on Fractyl Health’s Revita Procedure Boosts Buy Rating

Jason Gerberry, an analyst from Bank of America Securities, has initiated a new Buy rating on Fractyl Health,...

16d ago

GUTS

Promising Potential of Fractyl Health’s Revita Therapy Drives Buy Rating

Morgan Stanley analyst Michael Ulz has reiterated their bullish stance on GUTS stock, giving a Buy rating on...

17d ago

GUTS

Fractyl Health Announces $60M Stock Offering Pricing

The latest update is out from Fractyl Health, Inc. ( ($GUTS) ). On September 26, 2025, Fractyl Health,...

19d ago

GUTS

Fractyl Health Reveals Promising REMAIN-1 Study Results

The latest update is out from Fractyl Health, Inc. ( ($GUTS) ). On September 26, 2025, Fractyl Health...

19d ago

GUTS

Fractyl Health Appoints New Directors Amid Leadership Changes

Fractyl Health, Inc. ( ($GUTS) ) has provided an update. On August 29, 2025, Fractyl Health, Inc. announced...

1M ago

GUTS

GUTS FAQ

What was Fractyl Health, Inc.’s price range in the past 12 months?

Fractyl Health, Inc. lowest stock price was $0.82 and its highest was $3.48 in the past 12 months.

What is Fractyl Health, Inc.’s market cap?

Fractyl Health, Inc.’s market cap is $177.14M.

When is Fractyl Health, Inc.’s upcoming earnings report date?

Fractyl Health, Inc.’s upcoming earnings report date is Nov 18, 2025 which is in 34 days.

How were Fractyl Health, Inc.’s earnings last quarter?

Fractyl Health, Inc. released its earnings results on Aug 12, 2025. The company reported -$0.564 earnings per share for the quarter, missing the consensus estimate of -$0.36 by -$0.204.

Is Fractyl Health, Inc. overvalued?

According to Wall Street analysts Fractyl Health, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Fractyl Health, Inc. pay dividends?

Fractyl Health, Inc. does not currently pay dividends.

What is Fractyl Health, Inc.’s EPS estimate?

Fractyl Health, Inc.’s EPS estimate is -0.32.

How many shares outstanding does Fractyl Health, Inc. have?

Fractyl Health, Inc. has 132,193,770 shares outstanding.

What happened to Fractyl Health, Inc.’s price movement after its last earnings report?

Fractyl Health, Inc. reported an EPS of -$0.564 in its last earnings report, missing expectations of -$0.36. Following the earnings report the stock price went up 3.061%.

Which hedge fund is a major shareholder of Fractyl Health, Inc.?

Currently, no hedge funds are holding shares in GUTS

Fractyl Health, Inc. Stock Smart Score

Neutral

Fundamentals

Return on Equity

-379.75%

Trailing 12-Months

Asset Growth

-57.66%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Fractyl Health, Inc.

Fractyl Health, Inc. (GUTS) is a biotechnology company focused on transforming the treatment landscape for metabolic diseases, particularly type 2 diabetes and obesity. The company operates in the healthcare sector and is recognized for its innovative approach to metabolic health, leveraging advanced technologies to develop therapies that target the underlying causes of these conditions. Fractyl's core product is the Revita procedure, a minimally invasive endoscopic technique designed to improve metabolic function and promote weight loss through the modulation of gut hormones.

Fractyl Health, Inc. (GUTS) Earnings & Revenues

Historic Earnings Reports

GUTS Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

Fractyl Health's earnings call highlighted several positive developments, including a strengthened financial position, strategic focus on reducing cash burn, and promising data from the Revita program. However, the company also reported an increased net loss and highlighted dependence on future data readouts for continued success. The overall sentiment is cautiously optimistic, with significant potential contingent on upcoming results.View all GUTS earnings summaries

GUTS Stock 12 Month Forecast

Average Price Target

$6.52

▲(382.96% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","5":"$5","8":"$8","11":"$11","-1":"-$1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$10.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.52,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$6.52</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.60</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,2,5,8,11],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.47,2.126153846153846,2.7823076923076924,3.4384615384615382,4.094615384615384,4.75076923076923,5.406923076923077,6.063076923076922,6.7192307692307685,7.375384615384615,8.031538461538462,8.687692307692307,9.343846153846153,{"y":10,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.47,1.8584615384615384,2.246923076923077,2.6353846153846154,3.023846153846154,3.4123076923076923,3.800769230769231,4.189230769230769,4.577692307692308,4.966153846153846,5.354615384615385,5.743076923076923,6.131538461538462,{"y":6.52,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.47,1.6338461538461537,1.7976923076923077,1.9615384615384615,2.125384615384615,2.289230769230769,2.4530769230769227,2.6169230769230767,2.7807692307692307,2.9446153846153846,3.1084615384615386,3.272307692307692,3.4361538461538457,{"y":3.6,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6.74,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.73,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.84,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.06,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.84,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.56,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.11,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.27,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.9,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.58,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.81,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.98,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.47,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >